ATE361313T1 - Allgemeines verfahren zur rückfaltung rekombinanter proteine - Google Patents

Allgemeines verfahren zur rückfaltung rekombinanter proteine

Info

Publication number
ATE361313T1
ATE361313T1 AT00988440T AT00988440T ATE361313T1 AT E361313 T1 ATE361313 T1 AT E361313T1 AT 00988440 T AT00988440 T AT 00988440T AT 00988440 T AT00988440 T AT 00988440T AT E361313 T1 ATE361313 T1 AT E361313T1
Authority
AT
Austria
Prior art keywords
solution
adjusted
inclusion bodies
proteins
protein solution
Prior art date
Application number
AT00988440T
Other languages
English (en)
Inventor
Xinli Lin
Original Assignee
Oklahoma Med Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Med Res Found filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of ATE361313T1 publication Critical patent/ATE361313T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478Aspartic endopeptidases (3.4.23)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00988440T 2000-01-25 2000-12-28 Allgemeines verfahren zur rückfaltung rekombinanter proteine ATE361313T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17783600P 2000-01-25 2000-01-25
US17836800P 2000-01-27 2000-01-27
US21029200P 2000-06-08 2000-06-08
US21030600P 2000-06-08 2000-06-08

Publications (1)

Publication Number Publication Date
ATE361313T1 true ATE361313T1 (de) 2007-05-15

Family

ID=27497250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00988440T ATE361313T1 (de) 2000-01-25 2000-12-28 Allgemeines verfahren zur rückfaltung rekombinanter proteine

Country Status (12)

Country Link
US (3) US6583268B2 (de)
EP (1) EP1255769B1 (de)
JP (1) JP3929777B2 (de)
AT (1) ATE361313T1 (de)
AU (1) AU783545B2 (de)
CA (1) CA2397773C (de)
CY (1) CY1106768T1 (de)
DE (1) DE60034707T2 (de)
DK (1) DK1255769T3 (de)
ES (1) ES2287044T3 (de)
PT (1) PT1255769E (de)
WO (1) WO2001055174A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2374610A1 (en) * 1999-06-28 2001-01-04 Jordan J. N. Tang Catalytically active recombinant memapsin and methods of use thereof
DE60034707T2 (de) * 2000-01-25 2008-01-17 Oklahoma Medical Research Foundation, Oklahoma Allgemeines verfahren zur rückfaltung rekombinanter proteine
US7186539B1 (en) * 2001-08-31 2007-03-06 Pharmacia & Upjohn Company Method for refolding enzymes
WO2003039491A2 (en) 2001-11-09 2003-05-15 Georgetown University Novel isoforms of vascular endothelial cell growth inhibitor
US7166454B1 (en) * 2002-05-24 2007-01-23 Schering Corporation Codon-optimized β-secretase and methods of refolding and processing
CN1311076C (zh) * 2003-04-16 2007-04-18 普罗特奥姆技术公司 生产重组尿激酶的方法
JP2004345958A (ja) * 2003-05-13 2004-12-09 Universal Bio Research Co Ltd 蛋白質リフォールド装置および蛋白質リフォールド装置の使用方法
WO2005058930A2 (en) * 2003-12-11 2005-06-30 Proteomtech Inc. Methods for production of recombinant vascular endothelial cell growth inhibitor
WO2005058243A2 (en) * 2003-12-11 2005-06-30 Proteomtech Inc. Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a
JP2005173484A (ja) * 2003-12-15 2005-06-30 Canon Inc 画像形成装置及びプロセスカートリッジ
GB0405330D0 (en) * 2004-03-10 2004-04-21 Astrazeneca Ab Enzyme and preparation method
US20060107589A1 (en) 2004-11-19 2006-05-25 Rubin Patti D Compressed growing medium
US9756798B2 (en) 2004-11-19 2017-09-12 Patti D. Rubin Burrow filling compressed growing medium
US20060130159A1 (en) * 2004-12-09 2006-06-15 Nick Masiello Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
US7906625B2 (en) * 2005-01-24 2011-03-15 Amgen Inc. Humanized anti-amyloid antibody
US20070218535A1 (en) * 2005-11-28 2007-09-20 Xinli Lin Methods for production of recombinant alpha1-antitrypsin
BRPI0621124A2 (pt) 2005-12-22 2011-11-29 Genentech Inc métodos para recuperação de uma proteìna de ligação à heparina
WO2007081534A2 (en) * 2005-12-22 2007-07-19 Pfizer Products Inc Method of producing catalytically active bace2 enzymes
EP1845103B1 (de) * 2006-04-10 2015-02-25 Boehringer Ingelheim RCV GmbH & Co KG Verfahren zur Proteinfaltung
KR100723531B1 (ko) * 2006-06-13 2007-05-30 삼성전자주식회사 반도체 패키지 기판
AR062069A1 (es) * 2006-07-14 2008-10-15 Genentech Inc Replegado de proteinas recombinantes
US20100144622A1 (en) * 2006-09-29 2010-06-10 Xinli Lin Methods for production of recombinant plasminogen and plasmin polypeptides
US20100113355A1 (en) 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
WO2008132174A1 (en) * 2007-04-27 2008-11-06 Novartis Ag An immunoglobulin composition
WO2009058869A1 (en) 2007-10-29 2009-05-07 Oms Investments, Inc. Compressed coconut coir pith granules and methods for the production and use thereof
EP2235058A2 (de) 2007-12-21 2010-10-06 Amgen, Inc Anti-amyloid-antikörper und ihre verwendung
KR101063347B1 (ko) 2009-04-06 2011-09-07 인하대학교 산학협력단 이온성 액체를 이용한 이황화 결합을 포함하는 단백질의 재접힘 방법
WO2010117879A1 (en) 2009-04-08 2010-10-14 Ld Biopharma, Inc. Generating ips cells by protein transduction of recombinant potency-determining factors
US20160039868A1 (en) * 2013-03-22 2016-02-11 Biogenomics Limited Process for isolation and stabilisation of key intermediates for high efficiency refolding of recombinant proteins
US9982012B2 (en) 2013-03-29 2018-05-29 Dr. Reddy's Laboratories Limited Refolding of granulocyte colony stimulating factor
WO2016201608A1 (zh) * 2015-06-15 2016-12-22 张鹏 可独立用于蛋白质复性或作为蛋白质复性前导操作的方法
CN108822202B (zh) * 2018-02-07 2021-11-30 电子科技大学 一种草鱼白细胞介素21重组蛋白及其制备方法
CN116445462A (zh) * 2023-04-20 2023-07-18 西安麦博泰克生物科技有限公司 一种重组猪胃蛋白酶的纯化制备方法及重组猪胃蛋白酶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US20020049303A1 (en) * 1999-06-28 2002-04-25 Tang Jordan J. N. Catalytically active recombinant memapsin and methods of use thereof
CA2374610A1 (en) * 1999-06-28 2001-01-04 Jordan J. N. Tang Catalytically active recombinant memapsin and methods of use thereof
DE60034707T2 (de) 2000-01-25 2008-01-17 Oklahoma Medical Research Foundation, Oklahoma Allgemeines verfahren zur rückfaltung rekombinanter proteine
WO2003039491A2 (en) * 2001-11-09 2003-05-15 Georgetown University Novel isoforms of vascular endothelial cell growth inhibitor
TW200417864A (en) * 2003-03-11 2004-09-16 Benq Corp Electronic peripheral device and network interface card
WO2004094344A2 (en) 2003-04-16 2004-11-04 Proteomtech, Inc. Methods for production of recombinant urokinase
CN1311076C (zh) * 2003-04-16 2007-04-18 普罗特奥姆技术公司 生产重组尿激酶的方法
WO2005058930A2 (en) 2003-12-11 2005-06-30 Proteomtech Inc. Methods for production of recombinant vascular endothelial cell growth inhibitor
WO2005058243A2 (en) * 2003-12-11 2005-06-30 Proteomtech Inc. Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a

Also Published As

Publication number Publication date
DE60034707T2 (de) 2008-01-17
CA2397773A1 (en) 2001-08-02
PT1255769E (pt) 2007-07-23
US20060287504A1 (en) 2006-12-21
US20030199676A1 (en) 2003-10-23
AU783545B2 (en) 2005-11-10
US20010044521A1 (en) 2001-11-22
US6583268B2 (en) 2003-06-24
WO2001055174A2 (en) 2001-08-02
DE60034707D1 (de) 2007-06-14
JP2003523363A (ja) 2003-08-05
EP1255769B1 (de) 2007-05-02
AU2464901A (en) 2001-08-07
EP1255769A2 (de) 2002-11-13
CY1106768T1 (el) 2012-05-23
US7119166B2 (en) 2006-10-10
JP3929777B2 (ja) 2007-06-13
WO2001055174A3 (en) 2002-03-07
CA2397773C (en) 2008-09-02
ES2287044T3 (es) 2007-12-16
DK1255769T3 (da) 2007-09-03

Similar Documents

Publication Publication Date Title
ATE361313T1 (de) Allgemeines verfahren zur rückfaltung rekombinanter proteine
Fischer et al. Isolation, renaturation, and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies
DK1095056T3 (da) Höjtryksrefoldning af proteinaggregater og inklusionslegemer
Marston The purification of eukaryotic polypeptides synthesized in Escherichia coli
DK394786D0 (da) Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer
ATE513043T1 (de) Gegen denaturierungsmittel stabile und/oder proteaseresistente, chaperonähnliche oligomere proteine, diese kodierende polynukleotide sowie ihre verwendungen
DE60311731D1 (de) Verfahren zur rekombinanten Herstellung von Antifusogenikpeptide
NO20031839D0 (no) Fremgangsmåte for rensing og gjenvinning av proteiner
ATE455126T1 (de) Herstellung von rekombinantem bmp-2
ATE406377T1 (de) Verfahren um schwefelbrücken in fehlerhaft gefalteten fc molekülen zu korrigieren
FI93842B (fi) Menetelmä proteiinien renaturoimiseksi
DE3784555D1 (de) Isolierung von bioaktivem, monomerem wachstumshormon.
ATE111480T1 (de) Verfahren zur rückgewinnung rekombinanter proteine unter verwendung von flockungsmitteln.
Wolfson et al. Insertion of an elastase-binding loop into interleukin-1β
JP3070935B2 (ja) 変性組換え融合蛋白質のバイオ触媒的な正確な鎖フオールデイングのための方法
ATE86868T1 (de) Verfahren zur reinigung von interferon und so hergestellte zusammensetzung.
ATE76435T1 (de) Solubilisation und oxidation von somatotropin aus transformierten mikroorganismen.
DE60238938D1 (de) Verfahren zur renaturierung rekombinanter, disulfid-enthaltender proteine bei hohen proteinkonzentrationen in gegenwart von aminen
ATE516306T1 (de) Verbessertes verfahren zur reinigung von tfpi und tfpi-analogen
DE60117754D1 (de) Verfahren zur herstellung von rekombinantem trypsin
DE10299053I2 (de) Verfahren zur Verhinderung der Zersetzung des Proteins C.
Yon et al. New Strategy for Solubilization and Refolding of Recombinant Human Interferon a2b Inclusion Bodies from E. coli Gene Overexpression System.
RU2123010C1 (ru) Способ получения рекомбинантного интерферона-альфа-2 из нерастворимых тел включения
KR940014780A (ko) 성장호르몬의 봉입체로부터 활성형태의 성장호르몬을 제조하는 방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1255769

Country of ref document: EP

REN Ceased due to non-payment of the annual fee